HSBC to price 10% autocallable yield notes on pharmaceutical stocks

New York, June 29 – HSBC USA Inc. plans to price 10% autocallable yield notes due July 11, 2019 linked to the least performing of three pharmaceutical equities, the common stocks of AbbVie Inc., Merck & Co., Inc. and Pfizer Inc., according to a 424B2 filing with the Securities and Exchange Commission.

The notes will pay a quarterly coupon at an annual rate of at least 10%. The exact coupon will be set at pricing.

The notes will be called at par if each stock closes at or above its initial price on any quarterly observation date.

The payout at maturity will be par unless any stock finishes below its trigger level, 75% of the initial price, in which case investors will receive a number of shares of the worst performing stock equal to $1,000 divided by that stock’s initial price or, at the issuer’s option, the cash value of those shares.

HSBC Securities (USA) Inc. is the agent.

The notes will price on July 6 and settle on July 11.

The Cusip number is 40435FP27.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.